Related Experiment Video
Updated: Jul 18, 2026

Epicardial Outgrowth Culture Assay and Ex Vivo Assessment of Epicardial-derived Cell Migration
Published on: March 18, 2016
EPAS1 induction drives myocardial degeneration in desmoplakin-cardiomyopathy
Eirini Kyriakopoulou1, Sebastiaan J van Kampen1, Martijn Wehrens1
1Hubrecht Institute, Royal Netherlands Academy of Arts and Sciences (KNAW) and University Medical Center Utrecht, Utrecht, the Netherlands.
Insights
Pathogenic desmoplakin (DSP) variants cause arrhythmogenic cardiomyopathy (ACM) by disrupting mitochondrial function. Increased endothelial PAS domain-containing protein 1 (EPAS1) levels are linked to this degeneration, suggesting EPAS1 as a therapeutic target in DSP-cardiomyopathy.
Area of Science:
- Cardiology
- Molecular Biology
- Genetics
Background:
- Arrhythmogenic cardiomyopathy (ACM) is often caused by desmoplakin (DSP) gene mutations.
- DSP-cardiomyopathy leads to myocardial degeneration and arrhythmias, but mechanisms are unclear.
- Understanding these mechanisms is crucial for developing effective therapies.
Purpose of the Study:
- To investigate the molecular mechanisms underlying DSP-cardiomyopathy.
- To identify key regulators of myocardial degeneration in DSP-cardiomyopathy.
- To explore potential therapeutic targets for this condition.
Main Methods:
- Spatial transcriptomics was performed on an explanted heart from a patient with a pathogenic DSP variant.
- In vitro ACM models and additional explanted hearts were analyzed.
- Transcriptional and mitochondrial function analyses were conducted.
Main Results:
- Endothelial PAS domain-containing protein 1 (EPAS1) was identified as a potential regulator of mitochondrial homeostasis.
- Elevated EPAS1 levels correlated with mitochondrial dysfunction and hypoxic stress in DSP-cardiomyopathy.
- DSP-cardiomyopathy cardiomyocytes showed mitochondrial dysfunction, apoptosis, and impaired contractility linked to increased EPAS1.
Conclusions:
- EPAS1 is implicated as a key regulator of myocardial degeneration in DSP-cardiomyopathy.
- These findings may extend to other forms of arrhythmogenic cardiomyopathy.
- EPAS1 represents a potential therapeutic target for DSP-cardiomyopathy and related conditions.
Abstract:
Arrhythmogenic cardiomyopathy (ACM) is frequently attributed to desmosomal mutations, such as those in the desmoplakin (DSP) gene. Patients with DSP-cardiomyopathy are predisposed to myocardial degeneration and arrhythmias. Despite advancements, the underlying molecular mechanisms remain incompletely understood, thus limiting therapeutic options. Here, we employed spatial transcriptomics on an explanted heart from a patient with a pathogenic DSP variant. Our transcriptional analysis revealed endothelial PAS domain-containing protein 1 (EPAS1) as a potential regulator of mitochondrial homeostasis in stressed cardiomyocytes. Elevated EPAS1 levels were associated with mitochondrial dysfunction and hypoxic stress in both human-relevant in vitro ACM models and additional explanted hearts with genetic cardiomyopathy. Collectively, cardiomyocytes bearing pathogenic DSP variants exhibit mitochondrial dysfunction, increased apoptosis, and impaired contractility, which are linked to the increased EPAS1 levels. These findings implicate EPAS1 as a key regulator of myocardial degeneration in DSP-cardiomyopathy, which expand to other forms of ACM.
Related Concept Videos
Desmosomes
Myocarditis I: Introduction
Heart Failure II: Pathophysiology
Cardiomyopathy II: Dilated Cardiomyopathy
Cardiomyopathy III: Hypertrophic Cardiomyopathy

